Generalized Lipodystrophy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2025-09-17
FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for MYALEPT (metreleptin) submitted by Chiesi USA, Inc.
FDA approval · 2023-03-31
FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for MYALEPT (metreleptin) submitted by Chiesi USA, Inc.
FDA approval · 2022-02-28
FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for MYALEPT (metreleptin) submitted by Chiesi USA, Inc. The action updates the product's labeling/ap…
FDA approval · 2021-06-09
FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for MYALEPT (metreleptin) submitted by Chiesi USA, Inc., signaling regulatory approval of an updated…
FDA approval · 2020-07-13
FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
The FDA granted approval of a supplemental application for MYALEPT (metreleptin) filed by Chiesi USA, Inc.
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
FDA approval · 2020-05-15
FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for MYALEPT (metreleptin) submitted by Chiesi USA, Inc.
FDA approval · 2018-12-21
FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for MYALEPT (metreleptin) from Chiesi USA, Inc.
FDA approval · 2015-09-22
FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for MYALEPT (metreleptin) submitted by Chiesi USA, Inc. This action authorizes changes proposed …
FDA approval · 2015-08-27
FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for MYALEPT (metreleptin) submitted by Chiesi USA, Inc.
FDA approval · 2014-06-30
FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
FDA approves a supplemental application for MYALEPT (metreleptin) submitted by Chiesi USA, Inc.